References
Finch R, Bint A, Hunter P & White L: Preface, J (1996): Antimicrob, Chemother; 37 (Suppl A): pg iii.
Andriole V.T. (1993): The future of the Quinolones. Drugs; 45 (Suppl 2): 1 -7
Shimizu M. (1995): Quinolone Antibacterial Agents: their past, present and future. J Infect Chemother; 1: 16–29.
Baquero F & Canton R. (1996): In vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens. J Antimicrob Chemother; 37 (Suppl A): 1–18.
Montay C (1996): Pharmacokinetics of sparfloxacin in healthy volunteers and patineis: a review. J Antimicrob Chemother, 37 (Suppl A): 27–39.
Wise R & Honeybourne D (1996): A review of the penetration of Sparfloxacin into the lower respiratroy tract and sinuses. J antimicrob Chemother, 37 (Suppl A): 57–63.
Baba S & the Japanese Collaborative Study Croup of Sparfloxacin in Otorhinolaryngology (1993): Clinical studies of Sparfloxacin in the field of Otorhinolaryngology. Drugs 45 (Suppl 3): 329–330.
Cehanno P, Berche P & the Sinusitis Study Croup (1996): Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. J Antimicrob Chemother; 37 (Suppl A): 105–114.
Rubinstein E (1996): Safety profile of sparfloxacin in the treatment of respiratory tract infections. J Antimicrob Chemother; 37 (Suppl A): 145–160.
Mizuki Y, Fujiwara I & Yamaguchi T (1996): Pharmacokinetic interactions related to the chemical structures of fluoroquinolones. J Antimicrob Chemother 37 (Suppl A): 41–55.
Norrby SR & Lietman PS (1993): Safety and tolerability of fluoroquinolones. Drugs 45 (Suppl 3): 59–64.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mittal, R. Sparfloxacin: An Overview of Its Efficacy in ENT Infections. IJO & HNS 49, 415–421 (1997). https://doi.org/10.1007/BF02994667
Issue Date:
DOI: https://doi.org/10.1007/BF02994667